Campbell & CO Investment Adviser LLC Has $3.43 Million Stock Position in Maximus, Inc. $MMS

Campbell & CO Investment Adviser LLC boosted its stake in shares of Maximus, Inc. (NYSE:MMS) by 173.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,789 shares of the health services provider’s stock after acquiring an additional 30,948 shares during the quarter. Campbell & CO Investment Adviser LLC owned approximately 0.09% of Maximus worth $3,425,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd grew its stake in shares of Maximus by 17,533.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 526 shares during the last quarter. UMB Bank n.a. lifted its holdings in Maximus by 37.5% during the 2nd quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock worth $58,000 after buying an additional 227 shares in the last quarter. Bayforest Capital Ltd bought a new position in Maximus in the 2nd quarter valued at $61,000. Parkside Financial Bank & Trust raised its position in shares of Maximus by 21.7% during the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock worth $62,000 after acquiring an additional 157 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Maximus by 60.4% during the second quarter. GAMMA Investing LLC now owns 1,174 shares of the health services provider’s stock valued at $82,000 after acquiring an additional 442 shares during the period. 97.21% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, October 27th. Weiss Ratings upgraded shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $90.00.

Maximus Stock Performance

Shares of MMS stock opened at $84.02 on Monday. The stock has a market cap of $4.73 billion, a PE ratio of 15.47 and a beta of 0.57. The stock has a 50-day moving average of $87.40 and a 200-day moving average of $78.69. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. Maximus, Inc. has a one year low of $63.77 and a one year high of $92.63.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the firm earned $1.74 EPS. Maximus’s quarterly revenue was up 2.5% compared to the same quarter last year. As a group, sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Investors of record on Friday, November 14th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, November 14th. Maximus’s dividend payout ratio (DPR) is presently 22.10%.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total transaction of $146,284.60. Following the transaction, the insider directly owned 13,508 shares in the company, valued at approximately $1,227,336.88. The trade was a 10.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.